03:44 PM EDT, 05/28/2026 (MT Newswires) -- Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index rising 1.4% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.5%.

The iShares Biotechnology ETF (IBB) climbed 1.5%.

In corporate news, Eli Lilly's ( LLY ) weight-loss drugs secured coverage from the three largest US pharmacy benefit managers, the drugmaker said Thursday. Lilly shares gained 4.3%.

Agilent Technologies ( A ) stock jumped 18% after the company posted higher fiscal Q2 adjusted earnings and revenue, and raised its fiscal 2026 adjusted EPS guidance.

Illumina ( ILMN ) shares climbed 5% after it said it launched a whole-genome sequencing research workflow for molecular residual disease detection.

AstraZeneca's ( AZN ) durvalumab, plus Bacillus Calmette-Guerin, received approval by the Food and Drug Administration to treat adults with BCG-naive, high-risk non-muscle invasive bladder cancer, the FDA said Thursday. AstraZeneca ( AZN ) shares rose 0.2%.